Foroughi A, Arefpour A, Nikoofar A, Sanei M, Mahdavi S, Javadinia S
Asian Pac J Cancer Prev. 2023; 24(7):2369-2374.
PMID: 37505768
PMC: 10676487.
DOI: 10.31557/APJCP.2023.24.7.2369.
Ghannoum M, Roberts D, Goldfarb D, Heldrup J, Anseeuw K, Galvao T
Clin J Am Soc Nephrol. 2022; 17(4):602-622.
PMID: 35236714
PMC: 8993465.
DOI: 10.2215/CJN.08030621.
Benjamin R
Adv Exp Med Biol. 2020; 1257:1-10.
PMID: 32483726
DOI: 10.1007/978-3-030-43032-0_1.
Zhao H, Peng C, Ruan G, Zhou J, Li Y, Hai Y
Int J Clin Exp Med. 2015; 7(12):5429-36.
PMID: 25664052
PMC: 4307499.
Zhao H, Guo W, Peng C, Ji T, Lu X
Mol Biol Rep. 2009; 37(5):2509-15.
PMID: 19701692
DOI: 10.1007/s11033-009-9765-2.
A Randomized Comparison of two Short Intensive Chemotherapy Regimens in Children and Young Adults With Osteosarcoma: Results in Patients With Metastases: A Study of the European Osteosarcoma Intergroup.
Bramwell V, Burgers M, Souhami R, Taminiau A, van der Eijken J, Craft A
Sarcoma. 1997; 1(3-4):155-60.
PMID: 18521218
PMC: 2395371.
DOI: 10.1080/13577149778245.
Reduction in the toxicity of aminopterin--monoclonal-antibody conjugates by leucovorin.
Rowland A, Pietersz G
Cancer Immunol Immunother. 1994; 39(2):135-9.
PMID: 8044832
PMC: 11038524.
DOI: 10.1007/BF01525319.
The therapy of osteosarcoma by intraarterial cis-platinum an limb preservation.
Chuang V, Wallace S, Benjamin R, Jaffe N, Ayala A, Murray J
Cardiovasc Intervent Radiol. 1981; 4(4):229-35.
PMID: 6948613
DOI: 10.1007/BF02552525.
A microbiological assay for the measurement of methotrexate in biological fluids.
Icke G, Davis R, Thom J
J Clin Pathol. 1983; 36(10):1116-9.
PMID: 6413551
PMC: 498486.
DOI: 10.1136/jcp.36.10.1116.
Toxicity associated with combination chemotherapy for osteosarcoma: a report of the cooperative osteosarcoma study (COSS 80).
Jurgens H, Beron G, Winkler K
J Cancer Res Clin Oncol. 1983; 106 Suppl:14-8.
PMID: 6350313
DOI: 10.1007/BF00625045.
Ferrokinetics after high-dose methotrexate therapy.
Schalhorn A, Sauer H, Wilmanns W
Klin Wochenschr. 1981; 59(19):1109-13.
PMID: 6285071
DOI: 10.1007/BF01746198.
What has adjuvant chemotherapy of osteosarcoma achieved? Discussion paper.
Souhami R
J R Soc Med. 1983; 76(11):943-6.
PMID: 6195337
PMC: 1439653.
DOI: 10.1177/014107688307601111.
Adjuvant chemotherapy of cancer. A review of its current status.
Carter S
Drugs. 1986; 31(4):337-67.
PMID: 3519178
DOI: 10.2165/00003495-198631040-00004.
A trial of chemotherapy in patients with osteosarcoma (a report to the Medical Research Council by their Working Party on Bone Sarcoma.
Br J Cancer. 1986; 53(4):513-8.
PMID: 2871860
PMC: 2001430.
DOI: 10.1038/bjc.1986.81.
Surgical pathology of bone sarcomas.
Huvos A
World J Surg. 1988; 12(3):284-98.
PMID: 2840775
DOI: 10.1007/BF01655660.
Diagnostic value of serum tumor markers in skeletal metastasis of carcinomas.
Chigira M, Shinozaki T
Arch Orthop Trauma Surg. 1990; 109(5):247-51.
PMID: 1702981
DOI: 10.1007/BF00419937.
Vincristine-methotrexate combination chemotherapy and the influence of weight loss on experimental tumour growth.
Mulder J, van Putten L
Cancer Chemother Pharmacol. 1979; 3(2):111-6.
PMID: 292535
DOI: 10.1007/BF00254981.
Current impact of adjuvant chemotherapy in resectable cancer.
Rossi A, Bonadonna G
Cancer Chemother Pharmacol. 1979; 3(1):7-16.
PMID: 231489
DOI: 10.1007/BF00254414.
